EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effectiveness of Electrocautery, Topical Cidofovir, and Topical Sinecatechins for the Treatment of Anal High-Grade Squamous Intraepithelial Lesions in Persons With HIV: An Open-Label, Randomized Controlled Trial

Joaquin Burgos iD, Adrià Curran, Jorge Garcia iD, David Campany iD, Vicente Descalzo, Paula Suanzes iD, Jordi Navarro iD, Bibiana Planas, Marta Sanchiz, Stefania Landolfi, Carme Dinares, Javier Hernández-Losa und 1 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf086 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Joaquin Burgos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, …. Hauptthemen laut MEDLINE: Electrocoagulation, Cidofovir, HIV Infections, Catechin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Doubts remain about the best treatment for managing premalignant lesions (high-grade squamous intraepithelial lesions [HSIL]) associated with anal cancer.

Methods

The TREATAIN trial was an open-label, randomized study conducted at Hospital Vall d’Hebron (Spain). Persons with human immunodeficiency virus and anal HSIL were randomly assigned 1:1:1 to receive treatment with electrocautery, topical cidofovir 1% ointment, or topical sinecatechins 10%. The primary outcome was histological resolution of HSIL. Secondary outcomes included adverse events, participant satisfaction, human papillomavirus clearance, and HSIL recurrence.

Results

Between October 2020 and November 2022, 100 participants were enrolled (36 in the electrocautery arm, 28 in the cidofovir arm, and 36 in the sinecatechins arm). Modified intention-to-treat analysis showed a response rate of 69.4% (95% confidence interval [CI]: 54.4%–84.5%) of patients in the electrocautery group, 82.1% (95% CI: 67.9%–96.3%) in the cidofovir group, and 61.1% (95% CI: 45.2%–77%) in the sinecatechins group (P = .189). During the 48-week follow-up period, recurrence was observed in 7 participants (28%) in the electrocautery group, 7 (30.4%) in the cidofovir group, and 8 (36.4%) in the sinecatechins group (log-rank test, P = .811). Side effects were reported by 97.2% of patients in the electrocautery group, 85.7% in the cidofovir group, and 33% in the sinecatechins group (P < .001). Patients were more satisfied with the sinecatechins treatment (mean, 5.6 ± 0.4), followed by electrocautery (mean, 5.1 ± 0.8), while lower satisfaction was reported with cidofovir treatment (mean, 4.77 ± 0.96) (P < .001).

Conclusions

No statistically significant difference was observed in efficacy between treatments; in contrast, sinecatechins was the most accepted and well-tolerated treatment. Clinical Trials Registration. EudraCT: 2018-001730-18; ClinicalTrials.gov: NCT04055142.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectrocoagulationCidofovirHIV InfectionsCatechinSquamous Intraepithelial LesionsAntiviral AgentsAnus NeoplasmsHumansFemaleMaleMiddle AgedAdultAdministration, TopicalTreatment OutcomeAgedPapillomavirus Infections

Stichwörter der Autor:innen

cidofovirelectrocauteryhigh-grade squamous intraepithelial lesionpeople with HIVsinecatechins

Substanzen

CidofovirCatechinAntiviral Agents

Autor:innen und Institutionen

  • Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Pharmacy Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Anatomical Pathology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.

ORCID-Profile: Joaquin Burgos, Jorge Garcia, David Campany, Paula Suanzes, Jordi Navarro, Vicenç Falcó

Förderung

  • Instituto de Salud Carlos III
  • European Regional Development Fund

Zitieren

APA

Burgos, J., Curran, A., Garcia, J., Campany, D., Descalzo, V., Suanzes, P., Navarro, J., Planas, B., Sanchiz, M., Landolfi, S., Dinares, C., Hernández-Losa, J., & Falcó, V. (2025). Effectiveness of Electrocautery, Topical Cidofovir, and Topical Sinecatechins for the Treatment of Anal High-Grade Squamous Intraepithelial Lesions in Persons With HIV: An Open-Label, Randomized Controlled Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf086

Vancouver

Burgos J, Curran A, Garcia J, Campany D, Descalzo V, Suanzes P, et al. Effectiveness of Electrocautery, Topical Cidofovir, and Topical Sinecatechins for the Treatment of Anal High-Grade Squamous Intraepithelial Lesions in Persons With HIV: An Open-Label, Randomized Controlled Trial. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf086

BibTeX
@article{Burgos2025,
  author = {Burgos, Joaquin and Curran, Adrià and Garcia, Jorge and Campany, David and Descalzo, Vicente and Suanzes, Paula and Navarro, Jordi and Planas, Bibiana and Sanchiz, Marta and Landolfi, Stefania and Dinares, Carme and Hernández-Losa, Javier and Falcó, Vicenç},
  title = {Effectiveness of Electrocautery, Topical Cidofovir, and Topical Sinecatechins for the Treatment of Anal High-Grade Squamous Intraepithelial Lesions in Persons With HIV: An Open-Label, Randomized Controlled Trial},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf086}
}
Kostenlos starten →